Aug 4, 2016, 09:31
by
Michael Croft
August 04, 2016 | Two articles in the New England Journal of Medicine express concerns about clinical trial data sharing and propose limitations and safeguards to limit its impact. Risks include: misleading analyses, enormous cost, and patient privacy. CardioBrief